Release Date: 12/06/18 09:05 Summary: Net Tangible Asset Backing Price Sensitive: No Download Document 422.64KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%